Literature DB >> 1667396

Calmodulin-like activity in mycobacteria.

F A Salih1, N K Kaushik, P Sharma, G V Choudary, P S Murthy, T A Venkitasubramanian.   

Abstract

Calmodulin-like activity has been reported for the first time in mycobacterial species, namely Mycobacterium tuberculosis BCG and M. smegmatis ATCC 14468. The activity was mainly located in the soluble fraction of the mycobacterial cells, Radioimmunoassay revealed maximum levels of calmodulin in young growing cells (early logarithmic phase of growth). Calmodulin-dependent phosphodiesterase activation assay revealed low activity (22%) of partially purified calmodulin either due to insufficient amount of calmodulin to activate phosphodiesterase or due to the presence of some factors interfering with the assay. Calmodulin antagonists, viz. trifluoperazine and phenothiazine, significantly inhibited the 32Pi incorporation into mycobacterial phospholipids. Similar inhibition was observed when EGTA (which removes calcium) was added to the medium. Significant inhibition of 32Pi incorporation in the presence of calmodulin antagonists suggested the involvement of calmodulin in mycobacterial phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667396

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  8 in total

1.  Isolation and characterization of a calmodulin-like protein from Halobacterium salinarium.

Authors:  T Rothärmel; G Wagner
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

2.  Immunocytochemical localization of a calmodulinlike protein in Bacillus subtilis cells.

Authors:  D C Dominguez; H Adams; J H Hageman
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

Review 3.  Thioridazine: resurrection as an antimicrobial agent?

Authors:  H K R Thanacoody
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

4.  Natural products from the termite Nasutitermes corniger lowers aminoglycoside minimum inhibitory concentrations.

Authors:  Henrique D M Coutinho; Alexandre Vasconcellos; Hilzeth L Freire-Pessôa; Carlos A Gadelha; Tatiane S Gadelha; Geraldo G Almeida-Filho
Journal:  Pharmacogn Mag       Date:  2010-02-13       Impact factor: 1.085

5.  Reinforcing the membrane-mediated mechanism of action of the anti-tuberculosis candidate drug thioridazine with molecular simulations.

Authors:  Wojciech Kopec; Himanshu Khandelia
Journal:  J Comput Aided Mol Des       Date:  2014-03-01       Impact factor: 3.686

6.  Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis.

Authors:  Diana Machado; Tatiane S Coelho; João Perdigão; Catarina Pereira; Isabel Couto; Isabel Portugal; Raquel De Abreu Maschmann; Daniela F Ramos; Andrea von Groll; Maria L R Rossetti; Pedro A Silva; Miguel Viveiros
Journal:  Front Microbiol       Date:  2017-04-27       Impact factor: 5.640

7.  Termite usage associated with antibiotic therapy: enhancement of aminoglycoside antibiotic activity by natural products of Nasutitermes corniger (Motschulsky 1855).

Authors:  Henrique D M Coutinho; Alexandre Vasconcellos; Micheline A Lima; Geraldo G Almeida-Filho; Rômulo R N Alves
Journal:  BMC Complement Altern Med       Date:  2009-09-17       Impact factor: 3.659

8.  Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli.

Authors:  Diana Machado; Laura Fernandes; Sofia S Costa; Rolando Cannalire; Giuseppe Manfroni; Oriana Tabarrini; Isabel Couto; Stefano Sabatini; Miguel Viveiros
Journal:  PeerJ       Date:  2017-04-26       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.